New seven-year findings from CooperVision’s MiSight 1 day contact lens clinical trial shows no evidence of myopia control rebound in children 12 months after treatment has ended. Read more
World-leading rates of youth-onset type 2 diabetes revealed in northern Australia
A new study of youth-onset type 2 diabetes among Aboriginal and Torres Strait Islander young people across northern Australia has uncovered what is arguably the highest prevalence reported in any youth population globally within the past 25 years. Read more
Reducing cataract surgery wait to three months would prevent thousands of falls, Aussie research finds
New analysis conducted by leading Australian research institutes has found cutting wait times for cataract surgery to three months could significantly reduce the number of avoidable falls and save the health system millions of dollars. Read more
SA researchers lead the way in childhood glaucoma QoL research
Adelaide researchers have published the world’s first study documenting the lived experience of childhood glaucoma in adults, which they hope will lead to a first-of-its-kind quality of life (QoL) tool for the rare condition. Read more
Aussie researcher helps build AI system to detect 14 retinal abnormalities
Melbourne’s Monash University has contributed to an international project that successfully applied artificial intelligence (AI) technology to real-world retinal imagery, which may be able to detect diseases more accurately and on a larger scale. Read more
New glaucoma imaging tech wins 2021 ‘Quinlivan’ Research Grant
A UNSW researcher from the university’s Graduate School of Biomedical Engineering has been awarded Glaucoma Australia (GA)’s ‘Quinlivan’ Research Grant to develop a novel imaging technology for the early detection and monitoring of glaucoma. Read more
Silverstone’s optomap-guided OCT improves patient management
Two recent studies have demonstrated the Optos Silverstone device – combining ultra-widefield (UWF) fundus capture with optomap-guided swept source-OCT (SS-OCT) – can improve patient management and impact treatment decisions. Read more
Prof Robyn Guymer ‘thrilled’ by Phase 3 results of pegcetacoplan for dry AMD
Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been involved in, investigating a new therapy she says is the only intervention shown to significantly slow the growth of lesions in dry AMD. Read more
Aussie bionic eye project secures $2m cash injection
A breakthrough bionic eye that delivers high-fidelity visual and spatial perception for blind people is one of 22 industry-led collaborative R&D projects to share in $47.1 million from the Federal Government. Read more
Rewriting eye disease: Are we ready for gene therapies?
In 2020, ophthalmology became the first medical field in Australia to secure approval for a gene therapy. The one-off treatment can restore vision in people once resigned to a lifetime of blindness and is expected to pave the way for many more. MYLES HUME analyses the opportunities and challenges posed by ocular gene therapies. Read more